FDA warns CVS, others against selling unapproved eye products

Singapore News News

FDA warns CVS, others against selling unapproved eye products
Singapore Latest News,Singapore Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

The U.S. Food and Drug Administration on Tuesday warned eight companies, including pharmacy giants CVS Health Corp and Walgreens Boots Alliance , against manufacturing or marketing unapproved eye products.

The eye products addressed in the FDA'sare illegally marketed to treat conditions like conjunctivitis, cataract and glaucoma, the agency said, adding that such drugs pose an increased risk to users as they can bypass some of the body's natural defenses.

CVS on Tuesday said it has stopped the sale of its "Pink Eye Relief Eye Drops", and that customers who purchased the product could return it to the company's pharmacy for a full refund.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA warns CVS, Walgreens about marketing of unapproved eye productsFDA warns CVS, Walgreens about marketing of unapproved eye productsThe U.S. Food and Drug Administration this week warned CVS Health Corp. Walgreens Boots Alliance Inc. and several smaller consumer products companies about...
Read more »

FDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products By ReutersFDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products By ReutersFDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products
Read more »

When Should You Get the New COVID Booster?When Should You Get the New COVID Booster?The Food and Drug Administration (FDA) approved a new round of COVID boosters on Monday.
Read more »

4 big analyst picks: CVS picks up upgrade on 'attractive risk/reward,' per Wolfe By Investing.com4 big analyst picks: CVS picks up upgrade on 'attractive risk/reward,' per Wolfe By Investing.com4 big analyst picks: CVS picks up upgrade on 'attractive risk/reward,' per Wolfe
Read more »

Here are Tuesday's biggest analyst calls: Nvidia, Tesla, CVS, Oracle, Walmart, Meta, Disney and moreHere are Tuesday's biggest analyst calls: Nvidia, Tesla, CVS, Oracle, Walmart, Meta, Disney and moreHere are the biggest calls on Wall Street on Tuesday.
Read more »

SA germ-zapping robot-maker Xenex clears major FDA hurdleSA germ-zapping robot-maker Xenex clears major FDA hurdleThe U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device.
Read more »



Render Time: 2025-03-06 09:30:51